Increasing the flow
26 June 2020
Sophia Ktori discusses the combination of drug discovery and cloud computing to rapidly select new candidate molecules in the fight against COVID-19 with researchers Christoph Gorgulla and Haribabu Arthanari
Researchers at Harvard Medical School (HMS) have released an open source drug discovery platform, VirtualFlow, that harnesses supercomputing power to screen potentially billions of small organic compound structures in parallel, in the hunt for promising new drug molecules.
